From training room to OR, Intuitive Surgical’s da Vinci SimNow sharpens robot skills

Intuitive Surgical’s cloud-based SimNow platform turns the da Vinci console into a surgical simulator, giving hospitals a way to train and assess robotic surgeons without tying up real operating rooms.

Edited by ad hoc news Flagship & Bestseller Desk. Reviewed before publication on 06/15/2026 at 12:26 PM ET. Details in the imprint.

Hospitals that invest in a da Vinci surgical robot increasingly want something just as important as hardware: a way to train surgeons without risking patient safety or blocking scarce operating room time. Intuitive Surgical’s da Vinci SimNow platform answers that pressure by turning compatible da Vinci consoles into a connected simulator, so surgeons can log in, practice cases and receive objective performance feedback on demand. Intuitive’s product information describes SimNow as a cloud-based simulation environment that runs on the surgeon console, allowing interactive procedural training and skills assessment without a live patient.

How da Vinci SimNow works and where it fits in the OR

SimNow is built as a software layer that runs on supported da Vinci surgeon consoles, using the same hand controllers, vision system and foot pedals that surgeons use in real procedures, so the feel of the training session closely mirrors the experience in the operating room. According to Intuitive, the platform offers a library of skills drills and procedure-focused simulations that span core robotic tasks such as camera control, needle driving, suturing and energy use, as well as more complex workflows that resemble full cases. Because the simulations are executed via the cloud, hospitals can add or update content without upgrading the physical robot, and administrators can track usage and performance across multiple surgeons and locations through centralized dashboards.

One practical benefit for hospitals is scheduling: instead of reserving an OR for basic console familiarization, early-stage trainees can practice on SimNow during off hours on a parked system, while fully qualified surgeons can use the same environment to rehearse uncommon procedures or explore new techniques. Intuitive emphasizes objective metrics such as economy of motion, instrument path length and error counts to make performance more transparent, in contrast to traditional apprenticeship-style training that leans heavily on subjective observation. Independent clinical education groups have highlighted that structured simulation programs tend to shorten learning curves for technically demanding procedures, helping surgeons reach proficiency with fewer supervised live cases. To support this, Intuitive has worked simulation modules into broader training pathways that pair SimNow sessions with on-site proctorship and case observation, so the software acts as a foundation rather than a standalone curriculum. The American College of Surgeons has described simulation as a cornerstone of modern competency-based surgical education, and SimNow is Intuitive’s in-house answer to that demand in the robotic domain.

Strategically, SimNow is also a data engine: each training session can generate anonymized performance data that, over time, helps Intuitive better understand how surgeons use its systems and where common errors occur, informing both product design and new training content. While the company does not break out SimNow revenue separately, it reports that more than 15 million da Vinci procedures have been performed globally, and a growing share of hospitals are building formal robotic surgery programs that bundle capital equipment, service contracts and training solutions into multi-year agreements. Industry analysts have pointed out that such software and education offerings can deepen customer stickiness and smooth revenue between robot replacement cycles, a dynamic that matters for a company whose core da Vinci installed base has already surpassed 8,500 systems worldwide. In its latest investor presentation, Intuitive highlights training and digital tools, including simulation, as part of its long-term growth strategy alongside procedure volume expansion and new indications.

For Intuitive, platforms like SimNow are a way to extend the life and utility of its flagship da Vinci franchise at a time when competitors in surgical robotics are pushing into the market with their own systems and training ecosystems. The company has said that it plans to keep investing in surgeon education, credentialing support and digital tools to lower barriers to adoption for new robotic programs, which could help defend its leading share in soft-tissue robotics as procedure volumes grow in general surgery, urology and gynecology. Shares of Intuitive Surgical (US46120E6023) traded on NASDAQ at around $507 in recent sessions, giving the company a market value in the neighborhood of $180 billion as investors weigh how much software and training platforms like SimNow can contribute to sustaining that leadership over the long term.

da Vinci SimNow quick profile

• Product: da Vinci SimNow
• Manufacturer: Intuitive Surgical, Inc.
• Category: Flagship/Bestseller training and simulation platform
• Launch date: First introduced in the 2010s, expanded with cloud-based modules over subsequent years
• MSRP / Price: Pricing not publicly listed; typically bundled or licensed as part of broader da Vinci training and service agreements
• Availability: Offered to hospitals and surgical centers that operate compatible da Vinci systems in markets where Intuitive provides commercial support
• Target audience: Surgeons in training, experienced da Vinci users seeking skill refinement, and hospital education departments running robotic surgery programs
• Key differentiator / USP: Uses the actual da Vinci surgeon console with cloud-delivered simulations and objective performance metrics to mirror real robotic procedures without involving a patient

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.